How T cell selection affects the effectiveness of COVID-19 vaccines
The impact of T cell selection on vaccine durability
This study looks at how different types of T cells affect how long the immune protection from COVID-19 vaccines lasts, helping us understand how our past experiences with viruses can influence our response to new variants, which could lead to better vaccines in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10901918 on NIH RePORTER |
What this research studies
This research investigates how the selection of T cells influences the durability of immune responses generated by COVID-19 vaccines. By studying the human T cell memory and its response to the mRNA vaccines from Moderna and Pfizer/BioNTech, the research aims to understand how past exposures to antigens shape the immune response to new viral variants. The methodology includes analyzing T cell populations and their diversity over time using advanced sequencing techniques. This could provide insights into improving vaccine effectiveness against emerging variants.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have received COVID-19 vaccinations and are willing to participate in immune response assessments.
Not a fit: Patients who have not been vaccinated against COVID-19 or those with compromised immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to enhanced vaccine strategies that provide longer-lasting immunity against COVID-19 and its variants.
How similar studies have performed: Other research has shown promising results in understanding T cell responses to vaccines, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Su, Laura — University of Pennsylvania
- Study coordinator: Su, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.